HeartBeam Arrhythmia Assessment System Earns FDA Clearance
HeartBeam announced that the FDA has granted 510(k) clearance of the HeartBeam system for comprehensive arrhythmia assessment.
HeartBeam announced that the FDA has granted 510(k) clearance of the HeartBeam system for comprehensive arrhythmia assessment.
HeartBeam signed a partnership agreement with digital health solutions company LIVMOR to build a remote patient monitoring portal.
HeartBeam announced that the FDA has granted 510(k) clearance of the HeartBeam system for comprehensive arrhythmia assessment.